Guggenheim Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,184	Closed	-$247K	–	1866
2024 Q2	$247K	Buy	6,184 +1,573	+34%	+$65.2K	﹤0.01%	1705
2024 Q1	$202K	Buy	4,611 +133	+3%	+$6.87K	﹤0.01%	1793
2023 Q4	$277K	Sell	4,478 -1,571	-26%	-$82.5K	﹤0.01%	1704
2023 Q3	$278K	Sell	6,049 -78	-1%	-$4.25K	﹤0.01%	1651
2023 Q2	$352K	Sell	6,127 -5,739	-48%	-$254K	﹤0.01%	1609
2023 Q1	$445K	Sell	11,866 -6,303	-35%	-$207K	﹤0.01%	1536
2022 Q4	$509K	Buy	18,169 +4,096	+29%	+$119K	﹤0.01%	1479
2022 Q3	$395K	Sell	14,073 -1,171	-8%	-$38.2K	﹤0.01%	1568
2022 Q2	$531K	Sell	15,244 -15,911	-51%	-$568K	﹤0.01%	1557
2022 Q1	$1.12M	Sell	31,155 -3,036	-9%	-$86.1K	0.01%	1306
2021 Q4	$796K	Sell	34,191 -2,865	-8%	-$58.6K	﹤0.01%	1472
2021 Q3	$704K	Buy	+37,056	New	+$726K	﹤0.01%	1596
2017 Q2	–	Sell	-12,003	Closed	-$173K	–	2831
2017 Q1	$173K	Sell	12,003 -62,715	-84%	-$986K	﹤0.01%	2645
2016 Q4	$1.38M	Sell	74,718 -62,497	-46%	-$1.22M	﹤0.01%	1946
2016 Q3	$2.6M	Buy	137,215 +58,349	+74%	+$1.06M	0.01%	1442
2016 Q2	$1.27M	Sell	78,866 -18,799	-19%	-$265K	﹤0.01%	1872
2016 Q1	$1.17M	Buy	97,665 +4,995	+5%	+$58.9K	﹤0.01%	1954
2015 Q4	$1.32M	Sell	92,670 -16,971	-15%	-$224K	﹤0.01%	1932
2015 Q3	$1.28M	Sell	109,641 -4,899	-4%	-$73.5K	﹤0.01%	1948
2015 Q2	$2.01M	Buy	+114,540	New	+$1.79M	0.01%	1765